In the first model, ADX71943 reversed complete Freund adjuvant (CFA)- induced reductions in withdrawal thresholds in a dose-related manner, with a minimum effective oral dose of 10mg/kg. In
The technology is based on a naturally occurring polysialic acid, which extends active life of a protein. PSA is biodegradable, non-immunogenic and non-toxic and is, therefore, expected to
Novavax said that the decision was taken due to the companies’ inability to agree on acceptable terms of the proposed collaboration and to obtain the necessary funding commitments
Earlier, in 2009, GSK entered into strategic collaborations with two specialist companies, Prosensa and JCR Pharmaceuticals. The alliance with Prosensa, announced in October 2009, focuses on nucleic acid-based
The company’s Hafnarfjordur facility in Iceland is a manufacturing site which exports 95% of its products. After expansion, the SOD-site‘s capacity will increase to 1.5 billion tablets per
Satnam Butter, director of LPC, said: “APCER uses best in class, validated processes and technology. Their staff have excellent training and qualifications. Outsourcing our pharmacovigilance operations to the
In April 2009, Almirall signed a co-marketing agreement with Recordati, by virtue of which, Recordati grants Almirall marketing rights in Spain for Silodosin. Enrique Dominguez, general manager of
SUN Y7017 is an N-methyl-D-aspartate (NMDA) receptor antagonist developed by Merz Pharmaceuticals. This drug was approved for use in the treatment of AD by the EMEA in 2002,
The company gains right to 18 prescription drugs through this acquisition, which includes ImmuCyst, an immunotherapy for superficial bladder cancer; gelclair, an oral gel for the management of
The company has provided a literature review supporting it’s belief that administration of exogenous testosterone at doses resulting in morning testosterone levels within the normal range, render a
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.